Chrysoula is a neuroscientist with dual doctoral degrees from Sorbonne University (France) and the University of Minho (Portugal). Her research focuses on developing novel treatments for neurodegenerative and mental disorders, including Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), and depression. She has extensive experience in preclinical models, molecular biology, and data analysis. Currently, she works as an R&D Scientist at ResQ Biotech in Athens.

Engaged in the search for novel pharmaceutical compounds targeting neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS) and Alzheimer’s Disease. My research focuses on cell-based studies, including cell viability assays and imaging, as well as molecular analysis and flow cytometry.

Led research projects investigating the effects of environmental factors on brain plasticity and neurodegenerative disorders, incorporating animal experiments along with molecular, histological, and data analyses.

As part of a dynamic team, worked on preclinical animal studies involving pharmaceutical substance administration, behavioral testing, and data analysis.